Cellino

🚀 Today marks an extraordinary milestone at Cellino! We are thrilled to announce that our team has been awarded up to $25M in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS). This funding will drive the development of our ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicine. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable Approach) project is the first project funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement. With ARPA-H’s support, Cellino will build a cassette-based biomanufacturing technology capable of scaling the production of personalized induced pluripotent stem cells at hospitals nationwide to develop curative medicines for a range of chronic conditions for an increasingly diverse and aging U.S. patient population. We are excited to move closer to making “Your Cells, Your Cure™” a reality for millions of patients. We are thrilled about this opportunity to advance our goal of making patient-specific stem cell-derived therapies available for broad patient audiences. 📄 Read the full release: https://bwnews.pr/4gfrjlb #ARPAH #Biotech #AI #MachineLearning #PersonalizedMedicine #Collaboration #Innovation #RegenerativeMedicine #BiotechBreakthroughs #CellinoBio #YourCellsYourCure #Biomanufacturing

🚀 We’re excited to be here at Cell 2024 by Oxford Global in #London! Our CEO & Co-Founder, Nabiha Saklayen, will be speaking on Cellino’s vision for the future of personalized regenerative medicine on November 7-8. 🗓️ Don’t miss these key sessions: 🔹 November 7, 2024 | 4:35 PM - 5:25 PM GMT Panel Discussion - Advancing Cell Therapies: Exploring Quality Control & Personalized Medicine Integration 🎤 Nabiha will speak on a panel featuring Zhong Yu, Scientific Liaisons Manager at Axion BioSystems, Monica Raimo, Director of Product and Process Development at Glycostem Therapeutics, and Nicolas Weber, Quality Team Leader QC at Novartis, moderated by Philippe Henon, Founder & Chairman of the Board at CellProthera SAS. 🔹 November 8, 2024 at 2:45 PM GMT iPSCs and Stem Cell Therapy Development (Track 4): AI-Driven Biomanufacturing of Cell and Tissue Replacements. 🎤 Nabiha will present on Cellino’s optical bioprocess, which combines optics and image-guided machine learning for iPSC management, as well as optical cassette-based manufacturing for scalable production of cells and tissues. 👉 Explore the full agenda here: https://lnkd.in/gh3MaE7U #OxfordGlobal #NextGenBiomed #Biotech #AI #Innovation #RegenMed #Therapeutics #PersonalizedMedicine #YourCellsYourCure #CellinoBio

📢 We’re proud to announce that Jesse Mulcahy, Head of Automation at Cellino, will be a featured speaker at AMG World’s Future Labs, Automation & Technology Summit West in #SanDiego on November 12, 2024! Be sure to attend the following sessions: 🔷 11:45 AM – Building the Foundations for the Lab of the Future Jesse will moderate an opening session on developing the infrastructure, hardware, software, and IT support necessary for AI-driven analytics and data processing in labs. 🔷 5:30 PM – The Lab of Tomorrow: What’s Emerging for Future Labs and How Can We Plan for the Next Generation of Lab Technology? Jesse will join a panel to discuss the latest innovations in AI, robotics, IoT, and other technologies revolutionizing lab processes. The conversation will explore ways to overcome technical barriers, implement energy-efficient equipment, and use automation to unlock smarter workflows. 🎤 Panelists including Jesse: Dragan Djordjevic, Director, ML & Digital CMC Cell Therapy Development & Automation, Takeda Kalpesh Gupta, Director of Research Automation, Moderna Join us to stay ahead in lab technology and explore the latest advancements: https://lnkd.in/gJEPAqnK #FutureLabsWest #Automation #LabTechnology #AI #Innovation #Biotech #RegenerativeMedicine #DataAnalytics #CellinoBio #LabOfTheFuture

🚀 Thank you, Longwood Healthcare Leaders, for a fantastic Boston CEO Forum! We're thrilled that our Co-Founder & Chief Product Officer, Marinna Madrid, PhD, shared her insights on the "Biomanufacturing: Planning for Future Success" panel earlier this week. Marinna discussed Cellino’s scalable solutions for #biomanufacturing personalized medicines and how automation can enhance efficiency in autologous cell therapy manufacturing. Moderated by Andrew Obenshain, CEO of bluebird bio, the discussion highlighted key advancements in emerging biomanufacturing technologies. It was a pleasure connecting with Al Gianchetti, CEO of XyloCor Therapeutics, Inc., Avi Nandi, President, Cell & Gene Therapy of SK pharmteco, and Hari Pujar, COO of Tessera Therapeutics, to explore the challenges and opportunities shaping the future of personalized medicine. 🌟 #BostonCEO #BiotechLeaders #Biomanufacturing #RegenMed #Innovation #PersonalizedMedicine #FutureofMedicine #Therapeutics #Cellino #YourCellsYourCure

👏 We had an incredible time at #BioFuture2024! It was a pleasure connecting with industry leaders, and we were honored to have our CEO & Co-Founder, Nabiha Saklayen, join Susan Hockfield, President Emerita of Massachusetts Institute of Technology, for the Fireside Chat, "The Convergence of AI and Biomanufacturing: Pioneering the Future of Regenerative Medicine." Moderated by Kimberly Ha, Founder & CEO of KKH Advisors, Nabiha shared our journey from Kendall Square, the hub of Cambridge's innovation ecosystem, and highlighted the potential of #AI-driven processes in making cell-based regenerative therapies more accessible. A special thank you to Demy-Colton for inviting us to be part of this dynamic gathering, exploring innovations that advance personalized cell-based therapies. These meaningful discussions are essential as we work together to improve #healthcare outcomes for all patients! 🚀🌐 #DemyColton #Biotech #AI #MachineLearning #Innovation #RegenMed #Therapeutics #PersonalizedMedicine #FutureofHealthCare #YourCellsYourCure #CellinoBio

🌟 Explore the future of regenerative medicine at #BioFuture2024 this week! Join Nabiha Saklayen, Cellino CEO & Co-Founder, and Susan Hockfield, President Emerita of Massachusetts Institute of Technology, at 9 AM ET on Wednesday, October 30, for a Fireside Chat on "The Convergence of AI and Biomanufacturing: Pioneering the Future of Regenerative Medicine."  Moderator Kimberly Ha, Founder & CEO of KKH Advisors, will lead the discussion as they cover key topics including: 🔷 The shift from traditional therapeutics to personalized cellular therapies 🔷 How living medicines derived from a patient’s own cells can potentially cure chronic diseases 🔷 Challenges and opportunities in scaling regenerative medicine for widespread use 🔷 Recent advancements in biomanufacturing for cell therapies Register and find us on the BioFuture™ meeting platform from October 28-30 to connect at the event or request  a virtual one-to-one meeting: https://lnkd.in/gV-2q65m We can’t wait to connect and work together toward improving healthcare outcomes for all patients! 🚀 #DemyColton #Biotech #AI #MachineLearning #Innovation #RegenMed #Therapeutics #PersonalizedMedicine #FutureofHealthCare #YourCellsYourCure #CellinoBio

🚀 We’re excited for tomorrow’s Longwood Healthcare Leaders Boston CEO Forum! Marinna Madrid, PhD, our Co-Founder & Chief Product Officer, will be joining industry leaders to discuss the latest research and development of biomanufacturing technologies. She’ll be speaking on the panel "Biomanufacturing: Planning for Future Success," led by moderator Andrew Obenshain, CEO of bluebird bio, and will share Cellino’s scalable solutions to industrializing autologous cell-based therapies! Marinna will be joined by Al Gianchetti, CEO of XyloCor Therapeutics, Inc., and Hari Pujar, COO of Tessera Therapeutics. We can’t wait to see everyone there for another engaging conversation on advancing personalized regenerative medicines! 🙌 🗓️ Join us and register here:  https://bit.ly/4dT37mf #BostonCEO #Biomanufacturing #Leadership #RegenMed #Innovation #PersonalizedMedicine #FutureofMedicine #Therapeutics #Cellino #YourCellsYourCure

🚀 Less than a month to go until NextGen Biomed by Oxford Global’s Cell 2024 in #London! Featuring global leaders in the cell and gene therapy space, this conference offers a comprehensive outlook on advancements in every step of the CGT value chain. Our CEO & Co-Founder, Nabiha Saklayen, will be speaking at this premier gathering on November 7-8, 2024. Make sure to mark these sessions on your calendar: 🔹 November 7, 2024 from 10:00 AM - 11:00 AM GMT – Panel Discussion: Advancing Cell Therapies: Exploring Quality Control & Personalized Medicine Integration. 🎤 Nabiha will speak on a panel featuring Zhong Yu, Scientific Liaisons Manager at Axion BioSystems, Monica Raimo, Director of Product and Process Development at Glycostem Therapeutics, and Nicolas Weber, Quality Team Leader QC at Novartis, moderated by Philippe Henon, Founder & Chairman of the Board at CellProthera SAS. 🔹 November 8, 2024 from 1:30 PM - 2:00 PM GMT – iPSCs and Stem Cell Therapy Development (Track 4): AI-Driven Biomanufacturing of Cell and Tissue Replacements. 🎤 Nabiha will present on Cellino’s optical bioprocess, which combines optics and image-guided machine learning for iPSC management, as well as optical cassette-based manufacturing for scalable production of cells and tissues. Register and see the full agenda here: https://lnkd.in/gh3MaE7U #OxfordGlobal #NextGenBiomed #Biotech #AI #MachineLearning #Innovation #RegenMed #Therapeutics #PersonalizedMedicine #FutureofHealthCare #YourCellsYourCure #CellinoBio

🚀 Don’t Miss This Conversation! 🚀 Our Co-Founder & CEO Nabiha Saklayen sits down with our newest board member, Chris Gibson, Co-Founder and CEO of Recursion, to explore their journeys and the future of personalized regenerative medicine. In this candid conversation, they dive into: 🎯 Their journeys as founder-CEOs 🤝 Building multidisciplinary teams that thrive at the interface of technical fields 💡 Personal motivations driving their passion for creating transformative impact for patients 🤖 The role of AI in shaping the future of personalized regenerative medicine If you’re curious about leadership, team-building strategies, or the exciting intersection of AI and healthcare, you won’t want to miss this engaging discussion. 👉 Watch the full video here: https://lnkd.in/eUs7SEpa #Leadership #RegenerativeMedicine #AI #BiotechInnovation #FutureOfHealthcare #FoundersJourney #TeamBuilding #PersonalizedMedicine

🚨 **Exciting News!** 🚨 We are thrilled to announce that Chris Gibson, Ph.D., Co-Founder and CEO of Recursion, has joined the Cellino Board of Directors! 🎉 As an experienced founder-CEO, Chris brings deep expertise in scaling multi-disciplinary teams and pushing the boundaries of healthcare innovation using AI, along with a passion for developing novel therapies for patients with significant unmet medical need. As we continue on the exciting journey of making personalized regenerative therapies available to patients, we are humbled to have Chris’ invaluable expertise and leadership as part of our Board! 🚀🚀 Check out the full press release at: https://lnkd.in/eCtBUemy #BoardAnnouncement #Leadership #Biotech #Innovation #RegenerativeMedicine #FutureForward